This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Orexigen Therapeutics Inc (OREX)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 155.42M 104.24M 98.12M 78.33M
Receivables 6.83M 2.57M 0.00 0.00
Inventories 10.80M 1.20M 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 233.90M 211.33M 178.28M 138.89M
Property, Plant & Equipment, Gross 3.50M 2.92M 2.58M 1.96M
Accumulated Depreciation & Depletion 2.22M 2.06M 1.95M 1.88M
Property, Plant & Equipment, Net 1.28M 857.00K 630.00K 83.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.41M 798.00K 1.21M 177.00K
Total Non-Current Assets 2.69M 1.66M 1.84M 260.00K
Liabilities & Shareholder Equity
Total Assets 236.59M 212.98M 180.12M 139.15M
Accounts Payable 6.49M 4.24M 4.79M 3.81M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 1.35M 0.00 0.00 0.00
Total Current Liabilities 32.24M 29.71M 22.85M 25.11M
Long Term Debt 88.13M 83.91M 80.03M 0.00
Deferred Income Taxes 0.00 547.00K 0.00 0.00
Other Non-Current Liabilities 82.84M 76.47M 35.38M 38.57M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 170.97M 160.92M 115.41M 38.57M
Total Liabilities 203.21M 190.64M 138.26M 63.69M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 33.38M 22.34M 41.86M 75.47M
Common Par 146.00K 123.00K 105.00K 84.00K
Additional Paid In Capital 653.70M 574.25M 556.24M 512.17M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -620.69M -552.00M -514.48M -436.80M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 215.00K -26.00K -3.00K 15.00K
Total Capitalization 121.51M 106.25M 121.89M 75.47M
Total Equity 33.38M 22.34M 41.86M 75.47M
Total Liabilities & Stock Equity 236.59M 212.98M 180.12M 139.15M
Total Common Shares Outstanding 145.54M 123.46M 104.97M 84.41M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 131.13M 118.24M 96.49M 70.74M
Diluted Weighted Shares Outstanding 131.13M 118.24M 96.49M 70.74M
Number of Employees 67 47 50 41
Number of Part-Time Employees 0 3 1 2
OREX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

OREX Orexigen Therapeutics Inc

Chart of OREX

Analysts Ratings for OREX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 1 3
Moderate Buy 0 0 0 0
Hold 5 5 3 2
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET OREX ANALYST REPORT

OREX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs